Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 3/20 | 0.45 |
| ▸ | PRKCA | P17252 | 6/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10657479 | 0.89 | NAAA (0.44) | NAAAPRKCA | |
| SCHEMBL10657472 | 0.89 | NAAA (0.44) | NAAAPRKCA | |
| SCHEMBL21298963 | 0.86 | NAAA (0.43) | NAAAPRKCAPKMMEN1HTT | |
| SCHEMBL21298978 | 0.84 | NAAA (0.51) | NAAAPRKCAPKMMEN1HTT | |
| SCHEMBL23635423 | 0.81 | NAAA (0.34) | NAAAPKMMEN1HTTKMT2A | |
| SCHEMBL19722305 | 0.81 | NAAA (0.32) | NAAAPKMMEN1HTTKMT2A | |
| SCHEMBL19722014 | 0.77 | SPHK1 (0.39) | — | |
| SCHEMBL10705977 | 0.76 | NAAA (0.58) | NAAAPRKCAPKMMEN1HTT | |
| SCHEMBL9435105 | 0.76 | NAAA (0.62) | NAAAPRKCAPKMMEN1HTT | |
| SCHEMBL10705615 | 0.76 | NAAA (0.54) | NAAAPKMMEN1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10392339-B2 | Polymerizable polar compound, liquid crystal composition, and liquid crystal display element | JNC CORPORATION (JP) | 2019-08-27 | — | — | US | disclosed |
| WO-2018025974-A1 | LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE | JNC株式会社 | 2018-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10392339-B2 | Polymerizable polar compound, liquid crystal composition, and liquid crystal display element | SP1, HVCN1, CXCR1 | NAAA 4846/4885PRKCA 3450/4885PKM 2458/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.